טוען...
The place of intravenous immunoglobulin in rheumatic diseases
Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
IMA-PRESS LLC
2016-01-01
|
| סדרה: | Современная ревматология |
| נושאים: | |
| גישה מקוונת: | https://mrj.ima-press.net/mrj/article/view/655 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|